順發恆業(000631.SZ):17.19億元競得杭州蕭山區一幅地塊
格隆匯5月27日丨順發恆業(000631.SZ)公佈,2020年5月27日,公司全資子公司順發恆業有限公司通過公開競拍方式,以17.19億元人民幣競得蕭政儲出(2020)15號土地的國有建設用地使用權,並已獲得《競得入選人通知書》,後續將根據有關規定與杭州市規劃和自然資源局簽署《成交通知書》。
該地塊位於杭州市蕭山區寧圍區塊,東至通城快速路綠化帶、南至振寧路、西至萬向直路、北至規劃商住用地;土地出讓面積37476㎡;土地用途:住宅用地、商業用地。
此次競買土地使用權,可增加公司土地儲備,保障公司房地產業務實現可持續發展,有助於公司進一步提升未來的經營業績。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.